Symbols / AMRN
AMRN Chart
About
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Gen | Market Cap | 299.24M |
| Enterprise Value | 6.18B | Income | -86.19M | Sales | 226.73M |
| Book/sh | 22.06 | Cash/sh | 0.69 | Dividend Yield | — |
| Payout | 0.00% | Employees | 275 | IPO | — |
| P/E | — | Forward P/E | 24.39 | PEG | — |
| P/S | 1.32 | P/B | 0.65 | P/C | — |
| EV/EBITDA | -250.41 | EV/Sales | 27.24 | Quick Ratio | 2.27 |
| Current Ratio | 3.45 | Debt/Eq | 1.97 | LT Debt/Eq | — |
| EPS (ttm) | -4.20 | EPS next Y | 0.59 | EPS Growth | — |
| Revenue Growth | 17.40% | Earnings | 2026-02-25 | ROA | -2.46% |
| ROE | -17.41% | ROIC | — | Gross Margin | 54.96% |
| Oper. Margin | -3.42% | Profit Margin | -38.02% | Shs Outstand | 20.79M |
| Shs Float | 366.80M | Short Float | 2.93% | Short Ratio | 4.17 |
| Short Interest | — | 52W High | 20.90 | 52W Low | 7.00 |
| Beta | 0.86 | Avg Volume | 88.55K | Volume | 46.53K |
| Target Price | $12.00 | Recom | None | Prev Close | $15.52 |
| Price | $14.39 | Change | -7.27% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$12.00
Mean price target
2. Current target
$14.39
Latest analyst target
3. DCF / Fair value
$-16.97
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$14.39
Low
$12.00
High
$12.00
Mean
$12.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-06-25 | main | Goldman Sachs | Sell → Sell | $12 |
| 2025-04-17 | main | Goldman Sachs | Sell → Sell | $7 |
| 2024-06-20 | reit | Cantor Fitzgerald | — → Overweight | — |
| 2024-06-18 | reit | Cantor Fitzgerald | — → Overweight | — |
| 2023-10-25 | down | Jefferies | Buy → Hold | $1 |
| 2023-07-20 | main | Goldman Sachs | Sell → Sell | $1 |
| 2023-07-19 | main | Northland Capital Markets | Market Perform → Market Perform | $1 |
| 2023-01-06 | up | Jefferies | Hold → Buy | $3 |
| 2022-10-19 | main | SVB Leerink | — → Market Perform | $2 |
| 2022-05-24 | main | Goldman Sachs | — → Sell | $2 |
| 2022-05-06 | down | JP Morgan | Neutral → Underweight | — |
| 2022-05-05 | down | HC Wainwright & Co. | Buy → Neutral | $3 |
| 2022-05-05 | down | SVB Leerink | Outperform → Market Perform | $3 |
| 2022-02-16 | main | SVB Leerink | — → Outperform | $10 |
| 2022-01-31 | main | SVB Leerink | — → Outperform | $11 |
| 2021-09-09 | init | SVB Leerink | — → Outperform | $12 |
| 2021-05-12 | down | Goldman Sachs | Neutral → Sell | $5 |
| 2021-02-01 | main | SVB Leerink | — → Outperform | $16 |
| 2020-09-28 | main | SVB Leerink | — → Outperform | $12 |
| 2020-08-26 | init | Piper Sandler | — → Overweight | $21 |
- AMARIN ($AMRN) Releases Q4 2025 Earnings - Quiver Quantitative Wed, 25 Feb 2026 12
- Heart drug maker Amarin chops costs, trims Q4 loss to $1.2M - Stock Titan Wed, 25 Feb 2026 12
- Earnings call transcript: Amarin sees strategic gains in Q4 2025 amidst revenue decline - Investing.com Wed, 25 Feb 2026 14
- Amarin Corp (NASDAQ:AMRN) Narrows Losses and Beats Adjusted EPS in Q4 2025 - ChartMill Wed, 25 Feb 2026 13
- Amarin Corp Earnings Report: Q4 Overview - Benzinga Wed, 25 Feb 2026 12
- Amarin Q4 Earnings: Revenue Decline but Cash Increases - Intellectia AI Wed, 25 Feb 2026 12
- AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations - Yahoo Finance Fri, 09 Jan 2026 08
- Amarin Corporation plc (NASDAQ:AMRN) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - simplywall.st Sat, 04 Oct 2025 07
- Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom (NASDAQ:AMRN) - Seeking Alpha Mon, 29 Sep 2025 07
- Nearly half of U.S. adults have CVD, yet proven treatments go unused - Stock Titan Mon, 23 Feb 2026 13
- Avoiding Lag: Real-Time Signals in (AMRN) Movement - Stock Traders Daily Fri, 20 Feb 2026 15
- GNTA, BBIO, AMRN Jump After Hours: Key Biotech Catalysts Driving Stock Gains - Nasdaq Wed, 29 Oct 2025 07
- Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains? - Yahoo Finance Mon, 06 Oct 2025 07
- Leerink Partners raises Amarin stock price target to $12 on strong Q3 - Investing.com hu, 30 Oct 2025 07
- Do Options Traders Know Something About Amarin Stock We Don't? - Yahoo Finance hu, 23 Oct 2025 07
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 4179 | — | — | BERG AARON D. | Chief Executive Officer | — | 2026-01-30 00:00:00 | D | nan |
| 1 | 2396 | — | — | FISHMAN PETER L | Chief Financial Officer | — | 2026-01-30 00:00:00 | D | nan |
| 2 | 4179 | — | — | KEENAN DAVID PAUL | Chief Operating Officer | — | 2026-01-30 00:00:00 | D | nan |
| 3 | 4179 | — | — | KETCHUM STEVEN B | Officer | — | 2026-01-30 00:00:00 | D | nan |
| 4 | 3688 | — | — | PROVOOST JONATHAN | Officer | — | 2026-01-02 00:00:00 | D | nan |
| 5 | 2447 | — | — | FISHMAN PETER L | Chief Financial Officer | — | 2026-01-02 00:00:00 | D | nan |
| 6 | 3688 | — | — | KEENAN DAVID PAUL | Chief Operating Officer | — | 2026-01-02 00:00:00 | D | nan |
| 7 | 3688 | — | — | KETCHUM STEVEN B | Officer | — | 2026-01-02 00:00:00 | D | nan |
| 8 | 312 | — | — | FISHMAN PETER L | Chief Financial Officer | — | 2025-08-01 00:00:00 | D | nan |
| 9 | 75000 | — | — | BERG AARON D. | Chief Executive Officer | — | 2025-06-26 00:00:00 | D | nan |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | -2.30M | -2.84M | -4.33M |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.32 |
| NormalizedEBITDA | -74.18M | -39.73M | -87.17M | 27.99M |
| TotalUnusualItems | 0.00 | -10.97M | -13.53M | -13.72M |
| TotalUnusualItemsExcludingGoodwill | 0.00 | -10.97M | -13.53M | -13.72M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -82.18M | -59.11M | -105.80M | 7.73M |
| ReconciledDepreciation | 3.01M | 2.96M | 3.10M | 2.86M |
| ReconciledCostOfRevenue | 147.23M | 141.37M | 126.71M | 121.33M |
| EBITDA | -74.18M | -50.70M | -100.69M | 14.28M |
| EBIT | -77.19M | -53.66M | -103.79M | 11.42M |
| NetInterestIncome | 13.40M | 11.86M | 2.80M | 1.09M |
| InterestExpense | 7.00K | 8.00K | 15.00K | 129.00K |
| InterestIncome | 13.40M | 11.86M | 2.82M | 1.22M |
| NormalizedIncome | -82.18M | -50.44M | -95.12M | 17.12M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -82.18M | -59.11M | -105.80M | 7.73M |
| TotalExpenses | 320.41M | 363.53M | 461.54M | 558.97M |
| TotalOperatingIncomeAsReported | -91.80M | -67.59M | -105.87M | 10.50M |
| DilutedAverageShares | 20.55M | 20.38M | 20.06M | 20.12M |
| BasicAverageShares | 20.55M | 20.38M | 20.06M | 19.80M |
| DilutedEPS | -4.00 | -3.00 | -5.20 | 0.40 |
| BasicEPS | -4.00 | -3.00 | -5.20 | 0.40 |
| DilutedNIAvailtoComStockholders | -82.18M | -59.11M | -105.80M | 7.73M |
| NetIncomeCommonStockholders | -82.18M | -59.11M | -105.80M | 7.73M |
| NetIncome | -82.18M | -59.11M | -105.80M | 7.73M |
| NetIncomeIncludingNoncontrollingInterests | -82.18M | -59.11M | -105.80M | 7.73M |
| NetIncomeContinuousOperations | -82.18M | -59.11M | -105.80M | 7.73M |
| TaxProvision | 4.98M | 5.44M | 2.00M | 3.56M |
| PretaxIncome | -77.20M | -53.67M | -103.81M | 11.29M |
| OtherIncomeExpense | 1.20M | -8.91M | -14.27M | -14.02M |
| OtherNonOperatingIncomeExpenses | 1.20M | 2.06M | -740.00K | -302.00K |
| SpecialIncomeCharges | 0.00 | -10.97M | -13.53M | -13.72M |
| RestructuringAndMergernAcquisition | 0.00 | 10.97M | 13.53M | 13.72M |
| NetNonOperatingInterestIncomeExpense | 13.40M | 11.86M | 2.80M | 1.09M |
| InterestExpenseNonOperating | 7.00K | 8.00K | 15.00K | 129.00K |
| InterestIncomeNonOperating | 13.40M | 11.86M | 2.82M | 1.22M |
| OperatingIncome | -91.80M | -56.62M | -92.34M | 24.22M |
| OperatingExpense | 173.18M | 222.16M | 334.83M | 437.64M |
| ResearchAndDevelopment | 20.87M | 22.22M | 30.41M | 29.31M |
| SellingGeneralAndAdministration | 152.31M | 199.94M | 304.42M | 408.33M |
| SellingAndMarketingExpense | 79.59M | 111.33M | 185.61M | 266.47M |
| GeneralAndAdministrativeExpense | 72.72M | 88.61M | 118.80M | 141.86M |
| OtherGandA | 58.56M | 76.12M | 96.46M | 109.56M |
| SalariesAndWages | 14.17M | 12.49M | 22.34M | 32.30M |
| GrossProfit | 81.38M | 165.54M | 242.48M | 461.86M |
| CostOfRevenue | 147.23M | 141.37M | 126.71M | 121.33M |
| TotalRevenue | 228.61M | 306.91M | 369.19M | 583.19M |
| OperatingRevenue | 228.61M | 306.91M | 369.19M | 583.19M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 10.67M | 9.32M | 7.99M | 7.49M |
| OrdinarySharesNumber | 411.58M | 408.82M | 404.35M | 396.60M |
| ShareIssued | 422.26M | 418.14M | 412.33M | 404.08M |
| TotalDebt | 7.72M | 8.74M | 10.02M | 8.58M |
| TangibleBookValue | 469.79M | 532.79M | 573.55M | 643.55M |
| InvestedCapital | 486.18M | 552.10M | 595.33M | 667.10M |
| WorkingCapital | 415.45M | 465.70M | 429.62M | 508.05M |
| NetTangibleAssets | 469.79M | 532.79M | 573.55M | 643.55M |
| CapitalLeaseObligations | 7.72M | 8.74M | 10.02M | 8.58M |
| CommonStockEquity | 486.18M | 552.10M | 595.33M | 667.10M |
| TotalCapitalization | 486.18M | 552.10M | 595.33M | 667.10M |
| TotalEquityGrossMinorityInterest | 486.18M | 552.10M | 595.33M | 667.10M |
| StockholdersEquity | 486.18M | 552.10M | 595.33M | 667.10M |
| TreasuryStock | 65.33M | 63.75M | 61.77M | 60.73M |
| RetainedEarnings | -1.67B | -1.59B | -1.53B | -1.42B |
| AdditionalPaidInCapital | 1.91B | 1.90B | 1.89B | 1.86B |
| CapitalStock | 305.30M | 302.76M | 299.00M | 294.03M |
| CommonStock | 305.30M | 302.76M | 299.00M | 294.03M |
| TotalLiabilitiesNetMinorityInterest | 199.17M | 279.59M | 290.85M | 400.97M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 19.22M | 20.31M | 31.37M | 30.28M |
| OtherNonCurrentLiabilities | 11.50M | 9.06M | 8.21M | 7.65M |
| NonCurrentDeferredLiabilities | 0.00 | 2.51M | 13.15M | 14.06M |
| NonCurrentDeferredRevenue | 0.00 | 2.51M | 13.15M | 14.06M |
| LongTermDebtAndCapitalLeaseObligation | 7.72M | 8.74M | 10.02M | 8.58M |
| LongTermCapitalLeaseObligation | 7.72M | 8.74M | 10.02M | 8.58M |
| CurrentLiabilities | 179.95M | 259.28M | 259.48M | 370.68M |
| OtherCurrentLiabilities | 17.55M | 23.02M | 35.64M | 45.60M |
| CurrentDeferredLiabilities | 0.00 | 2.34M | 2.20M | 2.65M |
| CurrentDeferredRevenue | 0.00 | 2.34M | 2.20M | 2.65M |
| PayablesAndAccruedExpenses | 162.40M | 233.91M | 221.64M | 322.43M |
| CurrentAccruedExpenses | 122.04M | 181.15M | 157.03M | 207.51M |
| Payables | 40.37M | 52.76M | 64.60M | 114.92M |
| AccountsPayable | 40.37M | 52.76M | 64.60M | 114.92M |
| TotalAssets | 685.35M | 831.68M | 886.18M | 1.07B |
| TotalNonCurrentAssets | 89.95M | 106.70M | 197.08M | 189.34M |
| OtherNonCurrentAssets | 65.95M | 78.97M | 164.08M | 121.71M |
| InvestmentsAndAdvances | 0.00 | 1.27M | 35.00M | |
| GoodwillAndOtherIntangibleAssets | 16.39M | 19.30M | 21.78M | 23.55M |
| OtherIntangibleAssets | 16.39M | 19.30M | 21.78M | 23.55M |
| NetPPE | 7.61M | 8.42M | 9.95M | 9.09M |
| AccumulatedDepreciation | -1.47M | -1.38M | -2.47M | -1.92M |
| GrossPPE | 9.08M | 9.80M | 12.42M | 11.01M |
| Leases | 217.00K | 217.00K | 869.00K | 869.00K |
| OtherProperties | 7.59M | 8.31M | 9.07M | 7.66M |
| MachineryFurnitureEquipment | 1.27M | 1.28M | 2.48M | 2.48M |
| BuildingsAndImprovements | 9.07M | 7.66M | ||
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 595.40M | 724.98M | 689.10M | 878.73M |
| OtherCurrentAssets | 12.55M | 11.62M | 19.49M | 22.35M |
| RestrictedCash | 300.00K | 525.00K | 523.00K | 3.92M |
| PrepaidAssets | 22.35M | |||
| Inventory | 166.05M | 258.62M | 228.73M | 234.68M |
| Receivables | 122.28M | 133.56M | 130.99M | 163.65M |
| AccountsReceivable | 122.28M | 133.56M | 130.99M | 163.65M |
| AllowanceForDoubtfulAccountsReceivable | -10.79M | -27.12M | -56.43M | -99.30M |
| GrossAccountsReceivable | 133.07M | 160.69M | 187.42M | 262.95M |
| CashCashEquivalentsAndShortTermInvestments | 294.22M | 320.66M | 309.36M | 454.13M |
| OtherShortTermInvestments | 173.18M | 121.41M | 91.69M | 234.67M |
| CashAndCashEquivalents | 121.04M | 199.25M | 217.67M | 219.45M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -31.02M | 6.35M | -180.69M | -66.54M |
| RepaymentOfDebt | 0.00 | 0.00 | ||
| IssuanceOfCapitalStock | 0.00 | |||
| CapitalExpenditure | -533.00K | -599.00K | ||
| InterestPaidSupplementalData | 0.00 | 0.00 | ||
| IncomeTaxPaidSupplementalData | 3.98M | 2.37M | 1.78M | |
| EndCashPosition | 121.34M | 199.78M | 218.19M | 223.37M |
| BeginningCashPosition | 199.78M | 218.19M | 223.37M | 190.88M |
| ChangesInCash | -78.44M | -18.41M | -5.18M | 32.49M |
| FinancingCashFlow | -1.44M | 230.00K | -379.00K | -5.07M |
| CashFlowFromContinuingFinancingActivities | -1.44M | 230.00K | -379.00K | -5.07M |
| NetOtherFinancingCharges | -1.57M | -1.98M | -1.04M | -9.64M |
| ProceedsFromStockOptionExercised | 131.00K | 2.21M | 665.00K | 4.57M |
| NetCommonStockIssuance | 0.00 | |||
| CommonStockIssuance | 0.00 | |||
| NetIssuancePaymentsOfDebt | 0.00 | 0.00 | ||
| NetLongTermDebtIssuance | 0.00 | 0.00 | ||
| LongTermDebtPayments | 0.00 | 0.00 | ||
| InvestingCashFlow | -45.98M | -25.52M | 175.29M | 104.10M |
| CashFlowFromContinuingInvestingActivities | -45.98M | -25.52M | 175.29M | 104.10M |
| NetInvestmentPurchaseAndSale | -45.98M | -24.99M | 175.89M | 104.10M |
| SaleOfInvestment | 232.80M | 190.11M | 257.52M | 394.29M |
| PurchaseOfInvestment | -278.78M | -215.10M | -81.63M | -290.19M |
| NetIntangiblesPurchaseAndSale | 0.00 | -509.00K | -599.00K | 0.00 |
| PurchaseOfIntangibles | 0.00 | -509.00K | -599.00K | 0.00 |
| NetPPEPurchaseAndSale | 0.00 | -24.00K | 0.00 | 4.00K |
| PurchaseOfPPE | 0.00 | -24.00K | 0.00 | |
| OperatingCashFlow | -31.02M | 6.88M | -180.09M | -66.54M |
| CashFlowFromContinuingOperatingActivities | -31.02M | 6.88M | -180.09M | -66.54M |
| ChangeInWorkingCapital | 36.17M | 51.08M | -104.07M | -115.99M |
| ChangeInOtherWorkingCapital | -4.85M | -10.50M | -1.36M | -1.92M |
| ChangeInOtherCurrentLiabilities | 2.14M | 345.00K | 581.00K | 1.25M |
| ChangeInOtherCurrentAssets | 147.00K | -278.00K | -2.00K | -24.00K |
| ChangeInPayablesAndAccruedExpense | -76.99M | -164.00K | -102.73M | 51.52M |
| ChangeInAccruedExpense | 0.00 | 0.00 | ||
| ChangeInInterestPayable | 0.00 | 0.00 | ||
| ChangeInPayable | -76.99M | -164.00K | -102.73M | 51.52M |
| ChangeInAccountPayable | -76.99M | -164.00K | -102.73M | 51.52M |
| ChangeInPrepaidAssets | -934.00K | 7.87M | 2.86M | 8.60M |
| ChangeInInventory | 105.44M | 56.12M | -36.42M | -167.07M |
| ChangeInReceivables | 11.21M | -2.33M | 33.00M | -8.34M |
| ChangesInAccountReceivables | 11.28M | -2.57M | 32.66M | -9.08M |
| StockBasedCompensation | 17.70M | 15.65M | 26.21M | 36.94M |
| AmortizationOfSecurities | -5.73M | -3.70M | 473.00K | 1.93M |
| DepreciationAmortizationDepletion | 3.01M | 2.96M | 3.10M | 2.86M |
| DepreciationAndAmortization | 3.01M | 2.96M | 3.10M | 2.86M |
| AmortizationCashFlow | 2.92M | 2.81M | 2.54M | 2.27M |
| AmortizationOfIntangibles | 2.92M | 2.81M | 2.54M | 2.27M |
| Depreciation | 98.00K | 160.00K | 551.00K | 587.00K |
| NetIncomeFromContinuingOperations | -82.18M | -59.11M | -105.80M | 7.73M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for AMRN
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|